ESC Working Group Position Statement: Diagnosis and Treatment of Cardiac Amyloidosis (2021) 

Outlines red flags for suspicion, diagnostic pathways, imaging, biopsy, and management of cardiac amyloidosis subtypes (ATTR-CM and AL-CM). ESC Working Group Position Statement: Diagnosis and Treatment of Cardiac Amyloidosis (2021) 

Heart Rhythm Society (HRS) / American College of Cardiology (ACC) / American Heart Association (AHA) 2019 Expert Consensus on Arrhythmogenic Cardiomyopathy 

Provides detailed guidance on genetic evaluation, arrhythmia risk stratification, ICD therapy and exercise restriction in arrhythmogenic cardiomyopathy.

European Society of Cardiology (ESC) 2023 Guidelines for the Management of Cardiomyopathies

Covers all forms of cardiomyopathy across the life course, including hypertrophic, dilated, restrictive, arrhythmogenic and non-dilated left ventricular cardiomyopathy. Focuses on multimodality imaging, genetics, and multidisciplinary care.